Stuttering and Neuromodulation
ConditionStuttering
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNYU Langone Health
About this trial
The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity and negative impact in adults who stutter. The study also aims to explore neuroplastic changes (i.e., regional activation and functional connectivity) resulting from combined tDCS + speech therapy.
Eligibility criteria
Qualifiers
Adults aged 18 to 65 years.
Diagnosis of developmental stuttering, verified by a licensed speech-language pathologist.
Mild-to-moderate or greater stuttering severity, defined as a score of 20 or higher on the Stuttering Severity Instrument-Fourth Edition (SSI-4).
English as a primary language.
Disqualifiers
Have a history of neurological, psychiatric, or medical conditions that are contraindicated for tDCS.
Are currently taking medications known to affect cortical excitability.
Have a history of seizures or epilepsy.
Are pregnant or planning to become pregnant during the study period.
Trial design
Treatments tested in this trial
- Soterix Medical 1x1 tDCS system
- Speech therapy sessions
Treatment groups
16 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov